CAV1 and neoplasm: Meta-analysis of NSCLC patients [17] has revealed that although the Cav1 level is significantly lower in cancerous tissues than in non-neoplastic lung tissues, Cav1-expressing NSCLC patients have a higher risk of death and reduced progression-free survival, consistent with a role of Cav1 in tumor progression.